• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利流浪猫中产超广谱β-内酰胺酶、AmpCβ-内酰胺酶和碳青霉烯酶大肠杆菌的粪便携带情况

Fecal carriage of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli in stray cats in Italy.

作者信息

Ratti Gabriele, Facchin Alessia, Stranieri Angelica, Gazzonis Alessia, Penati Martina, Scarpa Paola, Dall'Ara Paola, Lauzi Stefania

机构信息

Department of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.

Department of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.

出版信息

Res Vet Sci. 2025 Mar;185:105560. doi: 10.1016/j.rvsc.2025.105560. Epub 2025 Jan 27.

DOI:10.1016/j.rvsc.2025.105560
PMID:39889451
Abstract

The spread of carbapenem-resistant bacteria is a global threat to public health and the role of pets in the rise in antimicrobial resistance is gaining attention worldwide. This study aimed to determine the fecal carriage of extended-spectrum β-lactamase (ESBL)-, AmpC- and carbapenemase (CP)-producing E. coli and associated risk factors in healthy and unhealthy stray cats admitted to the Veterinary Teaching Hospital of Lodi, University of Milan, Italy. Fecal samples collected in, 2020-2022 were microbiologically and molecularly analyzed. Overall, ESBL-/AmpC-/CP-producing E. coli were detected in 18/94 (19.1 %) stray cats. Twelve (12.8 %), 4 (4.3 %) and 7 (7.4 %) stray cats carried ESBL-, AmpC- and CP-producing E. coli phenotypes respectively, supported by the detection of bla in all ESBL-producing E. coli, bla in all AmpC-producing E. coli and bla (4/7; 57.1 %) or bla (3/7; 42.9 %) genes in CP-producing E. coli. Multiple combination of resistance genes and phenotypes were detected. MIC results showed that all E. coli were multidrug resistant isolates. Risk factors associated with ESBL-, AmpC- and/or CP-producing E. coli fecal carriage were hospitalization (P < 0.0001), antibiotic treatment during hospitalization (P < 0.0001) and unhealthy status (P < 0.0001). Fecal carriage of CP-producing E. coli is of concern and highlights the need of specific surveillance programs for CP-producing Enterobacteriaceae and antimicrobial stewardship in stray cats to reduce the emergence and spread of resistant bacteria. Limitations of this study suggest a One Health approach to characterize the whole genome of the isolates and the epidemiology of AMR bacteria among stray cats, including additional bacterial species and the environment.

摘要

耐碳青霉烯类细菌的传播是对全球公共卫生的威胁,宠物在抗菌药物耐药性上升中所起的作用正受到全球关注。本研究旨在确定意大利米兰大学洛迪兽医学院收治的健康和不健康流浪猫中产超广谱β-内酰胺酶(ESBL)、AmpC酶和碳青霉烯酶(CP)的大肠杆菌的粪便携带情况及相关危险因素。对2020年至2022年收集的粪便样本进行了微生物学和分子分析。总体而言,在94只流浪猫中的18只(19.1%)检测到产ESBL/AmpC/CP的大肠杆菌。分别有12只(12.8%)、4只(4.3%)和7只(7.4%)流浪猫携带产ESBL、AmpC和CP的大肠杆菌表型,所有产ESBL的大肠杆菌中bla的检测、所有产AmpC的大肠杆菌中bla的检测以及产CP的大肠杆菌中bla(4/7;57.1%)或bla(3/7;42.9%)基因的检测均支持这一结果。检测到耐药基因和表型的多种组合。MIC结果显示所有大肠杆菌均为多重耐药菌株。与产ESBL、AmpC和/或CP的大肠杆菌粪便携带相关的危险因素为住院(P<0.0001)、住院期间的抗生素治疗(P<0.0001)和不健康状态(P<0.0001)。产CP的大肠杆菌的粪便携带情况令人担忧,凸显了对流浪猫中产CP的肠杆菌科细菌进行特定监测计划以及抗菌药物管理以减少耐药菌出现和传播的必要性。本研究的局限性表明需要采用“同一健康”方法来鉴定分离株的全基因组以及流浪猫中抗菌药物耐药细菌的流行病学,包括其他细菌种类和环境。

相似文献

1
Fecal carriage of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli in stray cats in Italy.意大利流浪猫中产超广谱β-内酰胺酶、AmpCβ-内酰胺酶和碳青霉烯酶大肠杆菌的粪便携带情况
Res Vet Sci. 2025 Mar;185:105560. doi: 10.1016/j.rvsc.2025.105560. Epub 2025 Jan 27.
2
Fecal Carriage and Risk Factors Associated with Extended-Spectrum β-Lactamase-/AmpC-/Carbapenemase-Producing in Dogs from Italy.意大利犬类中产超广谱β-内酰胺酶/ AmpC酶/碳青霉烯酶的粪便携带情况及相关危险因素
Animals (Basel). 2024 Nov 21;14(23):3359. doi: 10.3390/ani14233359.
3
Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households.同一家庭中人类和宠物携带产超广谱β-内酰胺酶和 AmpC 酶的大肠埃希菌菌株。
Appl Environ Microbiol. 2020 Nov 24;86(24). doi: 10.1128/AEM.01613-20.
4
Fecal Carriage of Extended-Spectrum β-Lactamase-/AmpC-Producing in Pet and Stray Cats.宠物猫和流浪猫中产超广谱β-内酰胺酶/ AmpC的粪便携带情况
Antibiotics (Basel). 2023 Jul 29;12(8):1249. doi: 10.3390/antibiotics12081249.
5
Fecal carriage of carbapenemase and AmpC-β-lactamase producers among extended spectrum β-Lactamase-producing E. coli and Klebsiella spp. isolates in patients attending hospitals.在医院就诊患者中,产超广谱β-内酰胺酶的大肠埃希菌和克雷伯菌属分离株中碳青霉烯酶和AmpC-β-内酰胺酶产生菌的粪便携带情况。
BMC Infect Dis. 2025 Jan 23;25(1):109. doi: 10.1186/s12879-025-10506-4.
6
Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.从新西兰伴侣动物中分离出的产超广谱β-内酰胺酶和AmpCβ-内酰胺酶肠杆菌科细菌的特性分析。
N Z Vet J. 2017 Mar;65(2):105-112. doi: 10.1080/00480169.2016.1271730.
7
Carriage and population genetics of extended spectrum β-lactamase-producing Escherichia coli in cats and dogs in New Zealand.新西兰猫和犬中产extended spectrum β-lactamase-producing Escherichia coli 的携带和种群遗传学。
Vet Microbiol. 2019 Jun;233:61-67. doi: 10.1016/j.vetmic.2019.04.015. Epub 2019 Apr 12.
8
Occurrence of the Colistin Resistance Gene and Additional Antibiotic Resistance Genes in ESBL/AmpC-Producing Escherichia coli from Poultry in Lebanon: A Nationwide Survey.在黎巴嫩家禽中分离的产 ESBL/AmpC 酶大肠杆菌中黏菌素耐药基因和其他抗生素耐药基因的流行情况:一项全国性调查。
Microbiol Spectr. 2021 Oct 31;9(2):e0002521. doi: 10.1128/Spectrum.00025-21. Epub 2021 Sep 8.
9
Fecal Carriage of Extended-Spectrum β-Lactamases and pAmpC Producing in an Iranian Community: Prevalence, Risk Factors, Molecular Epidemiology, and Antibiotic Resistance.伊朗社区中产超广谱β-内酰胺酶和 pAmpC 型肠杆菌科细菌的粪便携带情况:流行率、危险因素、分子流行病学和抗生素耐药性。
Microb Drug Resist. 2022 Sep;28(9):921-934. doi: 10.1089/mdr.2021.0029. Epub 2022 Sep 5.
10
Fecal Carriage of Extended-Spectrum-β-Lactamase/AmpC-Producing in Horses.马中产超广谱β-内酰胺酶/头孢菌素酶的粪便携带情况。
Appl Environ Microbiol. 2020 Apr 1;86(8). doi: 10.1128/AEM.02590-19.